According to a recent study, the vast majority of people with depression across the world receive inadequate treatment or no care at all.
Published in the British Journal of Psychiatry, the study was conducted on around 50,000 people in 21 countries by King's College London, Harvard Medical School and the World Health Organization (WHO).
The research reports that of 4,331 people with depression across all 21 countries, treatment rates vary widely.
In high income countries only one in five people with depression receive adequate treatment.
The situation in the poorest countries of the world is far worse, where one in 27 people with depression receive adequate treatment.
Globally, an estimated 350 million people of all ages suffer from depression, and the condition is the leading cause of disability worldwide.
There is an increasing awareness that depression can be reliably diagnosed and treated in primary care settings using psychological therapy or medication, yet these scientifically proven and effective treatments are not being delivered on a wide scale.
The researchers analysed data from the WHO World Mental Health Surveys, a series of 23 community surveys in 21 countries.
These included 10 low or middle income countries (Brazil, Bulgaria, Colombia, Iraq, Lebanon, Mexico, Nigeria, People's Republic of China (PRC), Peru and Romania) and 11 high income countries (Argentina, Belgium, France, Germany, Israel, Italy, Japan, Netherlands, Portugal, Spain and the USA).
The researchers defined minimally adequate treatment as receiving either pharmacotherapy (at least one month of medication plus four or more visits to a doctor) or psychotherapy (at least eight visits with any professional including religious or spiritual advisor, social worker or counselor).
Graham Thornicroft, who led the study, said: "We call on national and international organizations to make adequate resources available for scaling up the provision of mental health services so that no one with depression is left behind."
Adding, "Our results indicate that much treatment currently offered to people with depression falls far short of the criteria for evidence-based and effective treatment."
Intriguingly, about half of all people with depression did not think they had a problem that needed treatment and this proportion fell to only a third in the poorest countries.
This strongly suggests that people also need to support individuals with depression and their family members to recognize that they have a treatable condition and should seek treatment and care.
"Providing treatment at the scale required to treat all people with depression is crucial, not only for decreasing disability and death by suicide, but also from a moral and human rights perspective, and to help people to be fully productive members of society," Thornicroft added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
